CLINICAL_TRIALS
research
· 2026-01-13
Clinical Trial Update: A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli [EARLY_Phase 1]
Summary
An early-phase randomized trial evaluating Yiqi Huoxue Jiedu Formula with bacteriophages for severe pneumonia caused by drug-resistant Gram-negative bacilli; th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Pneumonia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING